These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2907464)
1. Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat. Singh K; Orr JM; Abbott FS Drug Metab Dispos; 1988; 16(6):848-52. PubMed ID: 2907464 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and enterohepatic circulation of (E)-2-ene valproic acid in the rat. Singh K; Orr JM; Abbott FS J Pharmacobiodyn; 1990 Oct; 13(10):622-7. PubMed ID: 2095402 [TBL] [Abstract][Full Text] [Related]
3. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics. Tang W; Abbott FS Drug Metab Dispos; 1997 Feb; 25(2):219-27. PubMed ID: 9029053 [TBL] [Abstract][Full Text] [Related]
4. Capillary GCMS assay of 2-n-propyl-4-pentenoic acid (4-ene VPA) in rat plasma and urine. Singh K; Abbott FS; Orr JM Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):211-23. PubMed ID: 3602586 [TBL] [Abstract][Full Text] [Related]
5. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid. Kassahun K; Abbott F Drug Metab Dispos; 1993; 21(6):1098-106. PubMed ID: 7905390 [TBL] [Abstract][Full Text] [Related]
6. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status. Tang W; Borel AG; Fujimiya T; Abbott FS Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749 [TBL] [Abstract][Full Text] [Related]
7. Choleretic effect of valproic acid in the rat. Watkins JB; Klaassen CD Hepatology; 1981; 1(4):341-7. PubMed ID: 6793496 [TBL] [Abstract][Full Text] [Related]
8. Nonlinear elimination and cholerteic effect of valproic acid in the monkey. Dickinson RG; Taylor SM; Kaufman SN; Rodgers RM; Lynn RK; Gerber N; Baughman WL J Pharmacol Exp Ther; 1980 Apr; 213(1):38-48. PubMed ID: 6767022 [TBL] [Abstract][Full Text] [Related]
9. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116 [TBL] [Abstract][Full Text] [Related]
10. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid. Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993 [TBL] [Abstract][Full Text] [Related]
11. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid. Levy RH; Rettenmeier AW; Anderson GD; Wilensky AJ; Friel PN; Baillie TA; Acheampong A; Tor J; Guyot M; Loiseau P Clin Pharmacol Ther; 1990 Sep; 48(3):225-35. PubMed ID: 2119269 [TBL] [Abstract][Full Text] [Related]
12. The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes. Porubek DJ; Grillo MP; Baillie TA Drug Metab Dispos; 1989; 17(2):123-30. PubMed ID: 2565201 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat. Liu MJ; Brouwer KL; Pollack GM Drug Metab Dispos; 1992; 20(6):810-5. PubMed ID: 1362931 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. Kassahun K; Farrell K; Abbott F Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665 [TBL] [Abstract][Full Text] [Related]
15. Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat. Wright AW; Dickinson RG J Pharmacol Exp Ther; 2004 Aug; 310(2):584-8. PubMed ID: 15075379 [TBL] [Abstract][Full Text] [Related]
16. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat. Watkins JB; Klaassen CD J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642 [TBL] [Abstract][Full Text] [Related]
17. Characterization of thiol-conjugated metabolites of 2-propylpent-4-enoic acid (4-ene VPA), a toxic metabolite of valproic acid, by electrospray tandem mass spectrometry. Tang W; Abbott FS J Mass Spectrom; 1996 Aug; 31(8):926-36. PubMed ID: 8799319 [TBL] [Abstract][Full Text] [Related]
18. Lack of teratogenicity of trans-2-ene-valproic acid compared to valproic acid in rats. Vorhees CV; Acuff-Smith KD; Weisenburger WP; Minck DR; Berry JS; Setchell KD; Nau H Teratology; 1991 Jun; 43(6):583-90. PubMed ID: 1882349 [TBL] [Abstract][Full Text] [Related]
19. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. Rettenmeier AW; Prickett KS; Gordon WP; Bjorge SM; Chang SL; Levy RH; Baillie TA Drug Metab Dispos; 1985; 13(1):81-96. PubMed ID: 2858383 [TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. Kassahun K; Hu P; Grillo MP; Davis MR; Jin L; Baillie TA Chem Biol Interact; 1994 Mar; 90(3):253-75. PubMed ID: 8168173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]